Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis

Cecilia Melani, Antonella Stoppacciaro, Chiara Foroni, Federica Felicetti, Alessandra Caré, Mario P. Colombo

Research output: Contribution to journalArticlepeer-review

Abstract

The extracellular domain of the receptor tyrosine kinase Tie2/TEK (exTEK) has been used as an angiopoietin decoy to study the role of angiopoietins in the tumor-host interactions, using a syngeneic model of experimental metastases and subcutaneous tumor. Soluble exTEK secreted by transfected tumor cells inhibited HUVECs from forming tubes in Matrigel. ExTEK-transfected C26 colon carcinoma and TS/A mammary tumor cells displayed reduced growth rate when injected subcutaneously, and reduced ability to form experimental metastases when injected intravenously. Immunohistochemical analysis of tumors and metastases showed increased leukocytes infiltration and signs of inflammation in exTEK-secreting compared to parental tumor, as well as impairment in neo-vessel growth and organization. However, while neoangiogenesis eventually rescued in the subcutis, it failed to organize in the experimental metastases of exTEK-secreting tumor, contributing to the hampering of metastatic growth and to increased mice survival. The reactive infiltrate of C26TEK contained a different percentage of leukocytes and was responsible for the tumor inhibition. In fact, leukopenia induced by γ-irradiation of recipient mice or injection into interferon gamma (IFN-γ) gene knockout (GKO) mice resulted in reduced mouse survival and an increased number of lung metastases. On the other hand, interleukin (IL)-12 treatment prolonged the survival of mice bearing subcutaneous C26TEK but not of those bearing lung metastases, suggesting that IL-12 could exert further antiangiogenic effects at the site where the tumor can restore neoangiogenesis. These results show in vivo that reduced angiopoietin availability at the tumor site induces a local inflammatory response and impairment of neoangiogenesis which act synergistically to limit tumor growth and metastasis. Angiopoietins Decoy receptor Leukocyte infiltration Tumor angiogenesis Tumor inflammation.

Original languageEnglish
Pages (from-to)600-608
Number of pages9
JournalCancer Immunology, Immunotherapy
Volume53
Issue number7
DOIs
Publication statusPublished - Jul 2004

Keywords

  • Angiopoietins
  • Decoy receptor
  • Leukocyte infiltration
  • Tumor angiogenesis
  • Tumor inflammation

ASJC Scopus subject areas

  • Cancer Research
  • Immunology
  • Oncology

Fingerprint

Dive into the research topics of 'Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis'. Together they form a unique fingerprint.

Cite this